Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $10,570 - $18,795
3,500 Added 8.95%
42,600 $34,000
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $24,518 - $35,670
-8,200 Reduced 17.34%
39,100 $5,000
Q2 2022

Aug 12, 2022

BUY
$2.67 - $4.77 $6,675 - $11,924
2,500 Added 5.58%
47,300 $18,000
Q1 2022

May 12, 2022

SELL
$2.62 - $4.45 $262 - $445
-100 Reduced 0.22%
44,800 $13,000
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $63,180 - $83,772
15,600 Added 53.24%
44,900 $19,000
Q3 2021

Nov 10, 2021

BUY
$3.89 - $5.48 $6,224 - $8,768
1,600 Added 5.78%
29,300 $26,000
Q2 2021

Aug 11, 2021

BUY
$3.61 - $5.45 $19,494 - $29,430
5,400 Added 24.22%
27,700 $36,000
Q1 2021

May 14, 2021

SELL
$3.14 - $6.14 $76,616 - $149,816
-24,400 Reduced 52.25%
22,300 $20,000
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $49,046 - $110,696
27,400 Added 141.97%
46,700 $15,000
Q3 2020

Nov 13, 2020

SELL
$1.56 - $2.08 $53,976 - $71,968
-34,600 Reduced 64.19%
19,300 $6,000
Q2 2020

Aug 10, 2020

BUY
$0.94 - $2.21 $28,294 - $66,521
30,100 Added 126.47%
53,900 $7,000
Q1 2020

May 08, 2020

BUY
$0.84 - $1.76 $4,704 - $9,856
5,600 Added 30.77%
23,800 $3,000
Q4 2019

Feb 11, 2020

BUY
$1.14 - $1.49 $20,748 - $27,118
18,200 New
18,200 $1,000
Q1 2019

May 10, 2019

SELL
$1.14 - $2.25 $16,073 - $31,725
-14,100 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$1.02 - $2.05 $3,672 - $7,379
3,600 Added 34.29%
14,100 $0
Q3 2018

Nov 09, 2018

BUY
$1.01 - $2.19 $10,605 - $22,995
10,500 New
10,500 $2,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.75B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.